FoodMar 5, 2025
Arizona Foods Group FOOD SERVICE - Mombo s Vanilla Soft Serve Ice Cream Mix recall — FDA F-0572-2025
Product may contain egg, an undeclared allergen.
Class IFDA: TerminatedArizona Foods Group, Inc.
Latest records
Latest recalls — page 171
The newest recall records with useful source details are listed here.
DrugMar 5, 2025
Wuxi Medical lnstrument Factory Co ViaMed Alcohol Prep Pads, For External Use Only, 70% recall — FDA D-0247-2025
Lack of assurance of sterility and cGMP deviations observed at the manufacturing site.
Class IIFDA: OngoingWuxi Medical lnstrument Factory Co., Ltd.
DrugMar 5, 2025
Turbare Manufacturing Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection recall — FDA D-0248-2025
Lack of Assurance of Sterility: due to a quality control process deviation
Class IIFDA: CompletedTurbare Manufacturing
DrugMar 5, 2025
Padagis US Estradiol Gel, 0.1%, 0.25 mg/g, 30 packets per carton recall — FDA D-0246-2025
Defective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product.
Class IIFDA: CompletedPadagis US LLC
VehicleFeb 28, 2025
Ford control module (tcm/pcm/tecm) recall — NHTSA campaign 25V133000
Ford Motor Company (Ford) is recalling certain 2022-2024 Maverick, 2022 Escape, and 2021-2022 Lincoln Corsair vehicles previously repaired incorrectly under recall number 24V-330. The…
control module (tcm/pcm/tecm)Ford Motor Company
VehicleFeb 28, 2025
Ford integrated trailer brake control recall — NHTSA campaign 25V132000
Ford Motor Company (Ford) is recalling certain 2021-2022 F-150, 2022 Maverick, Expedition, Lincoln Navigator, F-250, F-350, F-450, and F-550 vehicles previously repaired incorrectly under…
integrated trailer brake controlFord Motor Company
FoodFeb 26, 2025
Apna Wholesale Paras Premium Golden Raisins recall — FDA F-0564-2025
Product contains undeclared sulfites (56.8mg/serving)
Class IFDA: TerminatedApna Wholesale Inc.
FoodFeb 26, 2025
Robin J Vos dba TS Food Packaging Bacon flavored Popcorn Seasoning packaged under the recall — FDA F-0570-2025
Undeclared allergen (soy).
Class IIFDA: TerminatedRobin J Vos dba TS Food Packaging
FoodFeb 26, 2025
NEW YORK WHOLESALE GROUP ZAARAH HERBALS brand SHATAVARI POWDER recall — FDA F-0567-2025
Product contains elevated levels of lead - 6.50 mg/kg (ppm)
Class IFDA: TerminatedNEW YORK WHOLESALE GROUP
FoodFeb 26, 2025
Jack & the Green Sprouts Alfalfa Sprouts recall — FDA F-0569-2025
Sprouts have the potential to be contaminated with Listeria monocytogenes
Class IFDA: OngoingJack & The Green Sprouts, Inc.
FoodFeb 26, 2025
Shata Traders THREE RIVERS brand TUTTI-FRUTTI recall — FDA F-0565-2025
Product contains undeclared FD&C Yellow 5 and FD&C Yellow 6.
Class IIFDA: TerminatedShata Traders Inc.
FoodFeb 26, 2025
United Natural Trading Inc. dba Woodstock Farms Wegmans, Organic Almonds Dry Roasted Salted recall — FDA F-0571-2025
Product mislabeled. The back label states Organic Cashews. The front product label states Wegmans Organic unsalted dry roasted almonds. The front label is correct label for this product.
Class IIFDA: TerminatedUnited Natural Trading Inc. dba Woodstock Farms
FoodFeb 26, 2025
Global Commodities AAHU BARAH brand SOFT PLUM recall — FDA F-0568-2025
Product contains undeclared sulfites (4.66 mg/serving).
Class IIFDA: OngoingGlobal Commodities Inc.
DrugFeb 26, 2025
Atomoxetine Capsules, USP, 40 mg, 30 capsule bottles recall — FDA D-0241-2025
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
DrugFeb 26, 2025
Atomoxetine Capsules, USP, 10 mg, 30 capsule bottles recall — FDA D-0238-2025
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
DrugFeb 26, 2025
Lorazepam Tablets, USP, 2mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs) recall — FDA D-0228-2025
Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.
Class IIFDA: OngoingThe Harvard Drug Group LLC dba Major Pharmaceuticals…
DrugFeb 26, 2025
Atomoxetine Capsules, USP, 60 mg, 30 capsule bottles recall — FDA D-0242-2025
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
DrugFeb 26, 2025
Lorazepam Tablets, USP, 1mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs) recall — FDA D-0227-2025
Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.
Class IIFDA: OngoingThe Harvard Drug Group LLC dba Major Pharmaceuticals…
DrugFeb 26, 2025
Silodosin Capsules, 8mg, 90-count bottle recall — FDA D-0229-2025
Subpotent Drug: Out of Specification (OOS) result for De hydro Impurity (0.654%) for 18 M Stability sample and low assay 94.9% (specification of NLT 95.0% NMT 105%)
Class IIFDA: OngoingAvKARE
DrugFeb 26, 2025
Atomoxetine Capsules, USP, 80 mg, 30 capsule bottles recall — FDA D-0243-2025
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
DrugFeb 26, 2025
Fentanyl Transdermal System CII, 25mcg/h recall — FDA D-0245-2025
Defective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.
Class IFDA: OngoingAlvogen, Inc
DrugFeb 26, 2025
Atomoxetine Capsules, USP, 25 mg, 30 capsule bottles recall — FDA D-0240-2025
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
DrugFeb 26, 2025
Atomoxetine Capsules, USP, 100 mg, 30 capsule bottles recall — FDA D-0244-2025
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
DrugFeb 26, 2025
Atomoxetine Capsules, USP, 18 mg, 30 capsule bottles recall — FDA D-0239-2025
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
Browse by month
Recent recall archives
Browse recent months with enough recall history for useful comparison.
August 2026149 records · 4 categoriesJuly 2026370 records · 4 categoriesJune 2026375 records · 4 categoriesMay 2026337 records · 4 categoriesApril 2026412 records · 4 categoriesMarch 2026183 records · 4 categoriesFebruary 2026330 records · 4 categoriesJanuary 2026211 records · 4 categoriesDecember 2025383 records · 4 categoriesNovember 2025277 records · 4 categoriesOctober 2025145 records · 3 categoriesSeptember 2025119 records · 3 categories